The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors announced it has approved $54.8 million in funding for 33 new patient-centered comparative clinical effectiveness research projects.
The projects will study health conditions, including CVD, diabetes, nervous system disorders and chronic conditions, among others, according to a press release.
"We're pleased to announce this new round of studies that complement and enhance our growing portfolio of patient-centered research projects designed to help patients and those who care for them make better-informed health and health care decisions," PCORI executive director Joe Selby, MD, MPH, said in the release.
The chosen projects are designed to compare various ways of delivering treatment and improving access to care, and will also include research targeting subpopulations such as older adults, racial and ethnic minorities, children and low-income patients, according to the release.
The projects followed funding approval announced by PCORI in September 2013, which was granted to institutions throughout 18 states and selected from 325 applicants. The grant review process included input from patients and caregivers, as well as clinicians and scientists. Assessment of each study was performed according to scientific merit, methodology and how well the studies might engage patients and other stakeholders, among other factors.
“These projects reflect the best of the innovative ideas brought to us by investigators guided by input from patients, family caregivers, clinicians and other health care stakeholders,” Selby said in the release. “As we refine our funding announcements, with an increasing focus on specific priority topics and larger pragmatic studies, we continue to benefit from and seek insightful proposals initiated by researchers and their stakeholder partners.”
According to the release, PCORI has awarded nearly $549 million in aid for 313 research studies since 2012, with a projected $1 billion to be awarded between 2014 and 2015. PCORI was established by Congress in 2010 as an independent, nonprofit organization to fund evidence-based, patient-centered clinical research.